Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 65 clinical trials
featured
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer

A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer

estrogen receptor
erbb2
breast cancer
tamoxifen
HER2
  • 378 views
  • 23 Nov, 2020
  • 1 location
featured
TOL2506A

A Phase 3, Single Arm, Open-Label Study Evaluating Ovarian Suppression Following Three-Month Leuprolide Acetate For Injectable Suspension(TOL2506) in Combination with Endocrine Therapy in Premenopausal Subjects with Hormone-Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

her2/neu-negative breast cancer
endocrine therapy
epidermal growth factor receptor
growth factor
HER2
  • 0 views
  • 29 Jul, 2021
  • 1 location
featured
Do you suffer from Hemorrhoids?

Do you suffer from Hemorrhoids?

  • 1312 views
  • 25 Mar, 2021
  • 1 location
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

This clinical trial is designed to be a multi-center prospective, parallel-controlled Phase III clinical study. In this study, the efficacy of tamoxifen versus toremifene shall be compared in

estrogen receptor
neutrophil count
toremifene
invasive breast cancer
cancer
  • 28 views
  • 21 Jan, 2021
  • 18 locations
Combination Chemotherapy and Trastuzumab in Treating Women With Stage I Stage II or Stage III HER2-Positive Breast Cancer

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. …

aromatase inhibitor
her2/neu-positive breast cancer
paclitaxel
HER2
trastuzumab
  • 33 views
  • 07 Nov, 2020
  • 1 location
Tamoxifen Therapy for Myotubular Myopathy

This is a phase 1 / 2, randomized, double-blinded, single cross-over study, with a washout period between treatment regimens, to test the efficacy and safety of tamoxifen therapy to improve

  • 0 views
  • 04 Jul, 2021
  • 4 locations
Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy

RATIONALE: Tamoxifen may slow the growth of tumor cells and may be an effective treatment for patients with metastatic bladder cancer that did not respond to previous chemotherapy

tumor cells
  • 28 views
  • 07 Nov, 2020
  • 1 location
Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle

will, some patients will have a thin endometrium as measured by sonography at the time of ovulation. This phenomenon may be associated with a lower chance to conceive. Tamoxifen is a similar

clomiphene
ovulation induction
secondary infertility
unexplained infertility
  • 29 views
  • 07 Nov, 2020
  • 1 location
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women

also been shown that decreasing density with a drug called tamoxifen has resulted in a decreased risk in breast cancer. The investigators are looking at the effect of hCG on breast density

tamoxifen
  • 20 views
  • 07 Nov, 2020
  • 1 location
Thin Endometrium Undergoing Frozen-thawed Embryo Transfer

. Previous studies have shown that tamoxifen has advantages for improving endometrial thickness. However, there is still a lack of evidence from randomized clinical trials comparing the efficacy between

  • 0 views
  • 23 Jan, 2021
  • 1 location